• 1. Excited state potential energy surfaces and their interactions in FeIVO active sites
  Shaun D. Wong,Edward I. Solomon Dalton Trans., 2014,43, 17567-17577
• 2. Emerging 2D hybrid nanomaterials: towards enhanced sensitive and selective conductometric gas sensors at room temperature
  Hanie Hashtroudi,Ian D. R. Mackinnon J. Mater. Chem. C, 2020,8, 13108-13126
• 3. Emulsion technologies for multicellular tumour spheroid radiation assays?
  Kay S. McMillan,Anthony G. McCluskey,Annette Sorensen,Marie Boyd,Michele Zagnoni Analyst, 2016,141, 100-110
• 4. Estimates of hydride ion stability in condensed systems: energy of formation and solvation in aqueous and polar-organic solvents
  Craig A. Kelly,David R. Rosseinsky Phys. Chem. Chem. Phys., 2001,3, 2086-2090
• 5. Excimer–monomer switch: a reaction-based approach for selective detection of fluoride?
  Qiao Song,Angela Bamesberger,Lingyun Yang,Haley Houtwed,Haishi Cao Analyst, 2014,139, 3588-3592

Introduction to tert-butyl (2S)-2-amino-4-ethylhexanoate (CAS No. 1998648-07-9)

Tert-butyl (2S)-2-amino-4-ethylhexanoate, identified by its Chemical Abstracts Service (CAS) number 1998648-07-9, is a specialized organic compound that has garnered significant attention in the field of pharmaceutical and biochemical research. This compound belongs to the class of amino esters, characterized by its unique structural configuration and functional properties. The presence of a tert-butyl group and a (2S)-configured amino acid derivative makes it a promising candidate for various synthetic applications, particularly in the development of novel therapeutic agents.

The structure of tert-butyl (2S)-2-amino-4-ethylhexanoate consists of a six-carbon chain with an amino group at the second position and an ester linkage at the terminal carbon. The (2S) configuration of the amino group is particularly noteworthy, as it influences the stereochemical properties of the molecule, which are critical in determining its biological activity. This stereochemistry has been extensively studied in the context of enzyme inhibition and receptor binding, making it a valuable scaffold for drug design.

In recent years, there has been a surge in research focused on amino acid derivatives as pharmacological tools. These compounds are often employed as intermediates in the synthesis of more complex molecules or as active ingredients themselves. The tert-butyl moiety, in particular, enhances the stability of the compound and can influence its solubility and metabolic pathways. This has led to its incorporation into various drug candidates aimed at treating neurological disorders, metabolic diseases, and inflammatory conditions.

One of the most compelling aspects of tert-butyl (2S)-2-amino-4-ethylhexanoate is its potential application in neurological research. The compound’s structural similarity to naturally occurring amino acids suggests that it may interact with neurotransmitter systems without causing significant off-target effects. Preliminary studies have indicated that derivatives of this compound may exhibit properties such as modulating acetylcholine release or inhibiting specific enzymes involved in neurodegenerative processes. These findings have opened up new avenues for investigating potential treatments for conditions like Alzheimer’s disease and Parkinson’s disease.

Furthermore, the pharmaceutical industry has shown interest in this compound due to its versatility as a building block for more complex molecules. Its ester functionality allows for further chemical modifications, enabling researchers to tailor its properties for specific applications. For instance, conjugating this compound with other bioactive molecules could lead to novel prodrugs or targeted delivery systems. Such innovations are crucial in improving drug efficacy and reducing side effects.

The synthesis of tert-butyl (2S)-2-amino-4-ethylhexanoate involves multi-step organic reactions that require precise control over reaction conditions and stereochemistry. Advanced synthetic techniques, such as chiral resolution and asymmetric synthesis, are often employed to ensure high enantiomeric purity. The availability of high-quality starting materials and well-established synthetic protocols has made this compound more accessible to academic and industrial researchers alike.

In terms of biological activity, early pharmacokinetic studies have revealed that this compound exhibits moderate solubility in aqueous solutions, which is advantageous for formulation development. Additionally, its stability under various storage conditions makes it suitable for long-term research applications. These characteristics have positioned it as a reliable tool for investigating biochemical pathways and testing new therapeutic hypotheses.

The growing body of research on tert-butyl (2S)-2-amino-4-ethylhexanoate underscores its significance in modern medicinal chemistry. As our understanding of molecular interactions continues to evolve, compounds like this one will play an increasingly vital role in discovering and developing next-generation pharmaceuticals. Their unique structural features offer a rich foundation for innovation, driving advancements across multiple therapeutic domains.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)